Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-21837

ABSTRACT: Expression data from unactivated vs. activated PBMCs

OTHER RELATED OMICS DATASETS IN: PRJNA127739PRJNA126921

PROVIDER: E-GEOD-21837 | ExpressionAtlas | 2015-09-15

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-21837-analysis-methods.tsv	Tabular
	E-GEOD-21837-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-21837-configuration.xml	Xml
	E-GEOD-21837-percentile-ranks.tsv	Tabular
	E-GEOD-21837.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 51

Similar Datasets

Homo sapiens

Project description:Expression data from unactivated vs. activated PBMCs

| PRJNA126921 | ENA

Homo sapiens

Project description:Expression data from unactivated vs. activated PBMCs (ion array)

| PRJNA127739 | ENA

Sen2020 - Metabolic alteration in PBMCs associated with type 1 diabetes

Project description:Genome-Scale draft model for Human Peripheral Blood Mononuclear Cells (PBMCs). A GEM for PBMCs was developed by applying the INIT algorithm on Human Metabolic Reconstruction (HMR 2.0) as a template model. GEMs were contextualised/ constrained for different conditions using expression datasets. The gene/transcript expression data obtained from PBMCs of Type 1 Diabetes progressors, non-progressors, and healthy controls were employed to score each reaction of HMR 2.0. For further detail please refer to Electronic Supplementary Information of Sen et.al, Metabolic alterations in immune cells associate with progression to type 1 diabetes, Diabetologia, 15/01/2020, (https://doi.org/10.1007/s00125-020-05107-6).

2020-03-11 | MODEL1905270001 | BioModels

JIA vs HD PBMC

Project description:To compare expression profile of JIA in active disease (JADAS>1) PBMCs vs HD PBMCs

2023-06-30 | GSE235572 | GEO

Gene expression data from CD34+ BMMCs/PBMCs from MPN patients vs. healthy controls

Project description:Gene expression data from CD34+ BMMCs/PBMCs from MPN patients vs. healthy controls

| PRJNA728082 | ENA

Human PBMCs: Healthy vs Diabetic nephropathy vs ESRD

Project description:Human PBMCs: Healthy vs Diabetic nephropathy vs ESRD

| PRJNA595989 | ENA

Homo sapiens

Project description:Gene expression data from yerba mate treated and non-treated cultured PBMCs activated with phytohemagglutinin

| PRJNA329094 | ENA

PRognosis Evaluation using in-Depth immune phenotyping and metagenomic analysis In Colorectal cancer Therapy

Project description:Interventions: Group 1: Surgical patients undergoing surgery for colorectal cancer: immunophenotyping by PBMCs and metagenomic analyses from stool, mucosa, and saliva samples perioperatively and during oncologic follow-up. Group 2: oncologic patients with chemo- / immune therapy without recent surgery: Immunophenotyping by PBMCs and metagenomic analyses from stool, mucosa and saliva samples during therapy and oncological follow-up. Group 3: healthy controls: Immunophenotyping by PBMCs and metagenomic analyses from stool, mucosa, and saliva samples at the time of screening colonoscopy. Primary outcome(s): Difference in the differential abundance of the colonic mucosa of patients with CRC vs. healthy controls for evaluation as diagnostic biomarkers based on metagenomic analyzes (microbial pattern) Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: diagnostic

| 2439680 | ecrin-mdr-crc

Gene expression data from CD34+ BMMCs/PBMCs from JAK2V617F positive MPN patients vs. Healthy controls

Project description:Gene expression data from CD34+ BMMCs/PBMCs from JAK2V617F positive MPN patients vs. Healthy controls

| PRJNA562260 | ENA

Homo sapiens PBMCs: pre-vaccination (stimulation vs. no stimulation with EV71 antigen) vs. post-vaccination (stimulation vs. no stimulation with EV71 antigen)

Project description:To characterize the primary and recall responses to EV71 vaccines, PBMC from 19 recipients before and after vaccination with EV71 vaccine are collected and their gene expression signatures after stimulation with EV71 antigen were compared. Four-condition experiment,pre-vaccination PBMCs (stimulation vs. no stimulation with EV71 antigen) vs. post-vaccination PBMCs (stimulation vs. no stimulation with EV71 antigen)

2015-09-03 | E-GEOD-72618 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data